Transplant Outcomes in Mucopolysaccharidoses

Seminars in Hematology

Volumn 47, Issue 1, 2010, Pages 59-69

  Prasad, Vinod K ^a   Kurtzberg, Joanne ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; THYMOCYTE ANTIBODY;

ADVERSE OUTCOME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN FUNCTION; CHIMERA; CLINICAL FEATURE; COGNITION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE CARRIER; DOSE RESPONSE; ENZYME ACTIVITY; EVENT FREE SURVIVAL; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEARING; HLA MATCHING; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; MAROTEAUX LAMY SYNDROME; MORBIDITY; MORQUIO SYNDROME; MUCOPOLYSACCHARIDOSIS; MUCOPOLYSACCHARIDOSIS TYPE 7; MUSCULOSKELETAL DEVELOPMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SANFILIPPO SYNDROME; THERAPY EFFECT; TREATMENT OUTCOME; VISION;

BLOOD DONORS; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MUCOPOLYSACCHARIDOSES; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 72449148318     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.10.008     Document Type: Article

References (84)

1. Neufeld E.F., and Muenzer J. The mucopolysaccharidosis. In: Sciver C., Beaudet A., Sly W.S., and Valle D. (Eds). The metabolic and molecular basis of inherited disease (2001), McGraw-Hill, New York 3421-3452
2. Clarke L.A., Wraith J.E., Beck M., Kolodny E.H., Pastores G.M., Muenzer J., et al. Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 123 (2009) 229-240
3. Desnick R.J. Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27 (2004) 385-410
4. Wraith J.E. Advances in the treatment of lysosomal storage disease. Dev Med Child Neurol 43 (2001) 639-646
5. Wraith J.E. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Exp Opin Pharmacother 6 (2005) 489-506
6. Krivit W., Aubourg P., Shapiro E., and Peters C. Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 6 (1999) 377-382
7. Orchard P.J., Blazar B.R., Wagner J., et al. Hematopoietic cell therapy for metabolic disease. J Pediatr 151 (2007) 340-346
8. Peters C., Shapiro E.G., and Krivit W. Hurler syndrome: past, present, and future. J Pediatr 133 (1998) 7-9
9. Prasad V.K., and Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant 41 (2008) 99-108
10. Fratantoni J.C., Hall C.W., and Neufeld E.F. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 162 (1968) 570-572
11. Muenzer J., and Fisher A. Advances in the treatment of mucopolysaccharidosis type I. N Engl J Med 350 (2004) 1932-1934
12. Muenzer J., Wraith J.E., and Clarke L.A. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123 (2009) 19-29
13. Neufeld E.F., and Fratantoni J.C. Inborn errors of mucopolysaccharide metabolism. Science 169 (1970) 141-146
14. Chua S.J., Bielecki R., Wong C.J., Yamanaka N., Rogers I.M., and Casper R.F. Neural progenitors, neurons and oligodendrocytes from human umbilical cord blood cells in a serum-free, feeder-free cell culture. Biochem Biophys Res Commun 379 (2009) 217-221
15. Kogler G., Sensken S., Airey J.A., Trapp T., Muschen M., Feldhahn N., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 35 (2004) 23-35
16. Tracy E., Aldrink J., Panosian J., Beam D., Thacker J., Reese M., et al. Isolation of oligodendrocyte-like cells from human umbilical cord blood. Cytotherapy 10 (2008) 518-525
17. Hess D.A., Craft T.P., Wirthlin L., Hohm S., Zhou P., Eades W.C., et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 26 (2008) 611-620
18. Yagi T., Matsuda J., Tominaga K., Suzuki K., and Suzuki K. Hematopoietic cell transplantation ameliorates clinical phenotype and progression of the CNS pathology in the mouse model of late onset Krabbe disease. J Neuropathol Exp Neurol 64 (2005) 565-575
19. Hobbs J.R., Hugh-Jones K., Barrett A.J., Byrom N., Chambers D., Henry K., et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 8249 (1981) 709-712
20. Krivit W., Pierpont M.E., Ayaz K., Tsai M., Ramsay N.K., Kersey J.H., et al. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med 311 (1984) 1606-1611
21. Boelens J.J. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis 29 (2006) 413-420
22. Boelens J.J., Rocha V., Aldenhoven M., Wynn R., O'Meara A., Michel G., et al. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with Hurler syndrome. Biol Blood Marrow Transplant 15 (2009) 618-625
23. Martin P.L., Carter S.L., Kernan N.A., Sahdev I., Wall D., Pietryga D., et al. Results of the Cord Blood Transplantation Study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 12 (2006) 184-194
24. Prasad V.K., Mendizabal A., Parikh S.H., Szabolcs P., Driscoll T.A., Page K., et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112 (2008) 2979-2989
25. Staba S.L., Escolar M.L., Poe M., Kim Y., Martin P.L., Szabolcs P., et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 350 (2004) 1960-1969
26. Krivit W., Lockman L.A., Watkins P.A., Hirsch J., and Shapiro E.G. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 18 (1995) 398-412
27. Bjoraker K.J., Delaney K., Peters C., Krivit W., and Shapiro E.G. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation. J Dev Behav Pediatr 27 (2006) 290-296
28. Boelens J.J., Wynn R.F., O'Meara A., Veys P., Bertrand Y., Souillet G., et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 40 (2007) 225-233
29. Church H., Tylee K., Cooper A., Thornley M., Mercer J., Wraith E., et al. Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease. Bone Marrow Transplant 39 (2007) 207-210
30. Cox-Brinkman J., Boelens J.J., Wraith J.E., O'Meara A., Veys P., Wijburg F.A., et al. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant 38 (2006) 17-21
31. Dusing S.C., Rosenberg A., Hiemenz J.R., Piner S., and Escolar M. Gross and fine motor skills of children with Hurler syndrome (MPS-IH) post umbilical cord blood transplantation: a case series report. Pediatr Phys Ther 17 (2005) 264-267
32. Field R.E., Buchanan J.A., Copplemans M.G., and Aichroth P.M. Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development. J Bone Joint Surg Br 76 (1994) 975-981
33. Grigull L., Beilken A., Schrappe M., Das A., Luecke T., Sander A., et al. Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler). Bone Marrow Transplant 35 (2004) 265-269
34. Guffon N., Souillet G., Maire I., Straczek J., and Guibaud P. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133 (1998) 119-125
35. Peters C., Balthazor M., Shapiro E.G., King R.J., Kollman C., Hegland J.D., et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87 (1996) 4894-4902
36. Phipps S., and Mulhern R. Developmental outcome of unrelated donor bone marrow transplantation in children with Hurler syndrome. Blood 89 (1997) 732-734
37. Souillet G., Guffon N., Maire I., Pujol M., Taylor P., Sevin F., et al. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 31 (2003) 1105-1117
38. Tolar J., Grewal S.S., Bjoraker K.J., Whitley C.B., Shapiro E.G., Charnas L., et al. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplant 41 (2008) 531-535
39. Whitley C.B., Ramsay N.K., Kersey J.H., and Krivit W. Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction. Birth Defects 22 (1986) 7-24
40. Whitley C.B., Belani K.G., Chang P.N., Summers C.G., Blazar B.R., Tsai M.Y., et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet 46 (1993) 209-218
41. Aldenhoven M., Boelens J.J., and de Koning T.J. The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 14 (2008) 485-498
42. Vellodi A. Lysosomal storage disorders. Br J Haematol 128 (2005) 413-431
43. Peters C., Shapiro E.G., Anderson J., Henslee-Downey P.J., Klemperer M.R., Cowan M.J., et al., The Storage Disease Collaborative Study Group. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91 (1998) 2601-2608
44. Vellodi A., Young E.P., Cooper A., Wraith J.E., Winchester B., Meaney C., et al. Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 76 (1997) 92-99
45. Hopwood J.J., Vellodi A., Scott H.S., Morris C.P., Litjens T., Clements P.R., et al. Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J Inherit Metab Dis 16 (1993) 1024-1033
46. Belani K.G., Krivit W., Carpenter B.L., Braunlin E., Buckley J.J., Liao J.C., et al. Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings. J Pediatr Surg 28 (1993) 403-408
47. Braunlin E., Key-Bojack S., Panoskaltsis-Mortari A., Berry J.M., McElmurry R.T., Riddle M., et al. Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome. Pediatr Res 59 (2006) 27-32
48. Gatzoulis M.A., Vellodi A., and Redington A.N. Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation. Arch Dis Child 73 (1995) 259-260
49. Vinallonga X., Sanz N., Balaguer A., Miro L., Ortega J.J., and Casaldaliga J. Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone marrow transplantation. Pediatr Cardiol 13 (1992) 107-109
50. Hite S.H., Peters C., and Krivit W. Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H). Pediatr Radiol 30 (2000) 464-470
51. Fleming D.R., Henslee-Downey P.J., Ciocci G., Romond E.H., Marciniak E., Munn R.K., et al. The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I. Pediatr Transplant 2 (1998) 299-304
52. Khanna G., Van Heest A.E., Agel J., Bjoraker K., Grewal S., Abel S., et al. Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation. Bone Marrow Transplant 39 (2007) 331-334
53. Walkley S.U. Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol 15 (2004) 433-444
54. Gullingsrud E.O., Krivit W., and Summers C.G. Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up. Ophthalmology 105 (1998) 1099-1105
55. Tzetzi D., Hamilton R., Robinson P.H., and Dutton G.N. Negative ERGs in mucopolysaccharidoses (MPS) Hurler-Scheie (I-H/S) and Hurler (I-H)-syndromes. Doc Ophthalmol 114 (2007) 153-158
56. Shapiro E.G., Lockman L.A., Balthazor M., and Krivit W. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 18 (1995) 413-429
57. Weisstein J.S., Delgado E., Steinbach L.S., Hart K., and Packman S. Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation. J Pediatr Orthop 24 (2004) 97-101
58. Odunusi E., Peters C., Krivit W., and Ogilvie J. Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention. J Pediatr Orthop 19 (1999) 270-274
59. Masterson E.L., Murphy P.G., O'Meara A., Moore D.P., Dowling F.E., and Fogarty E.E. Hip dysplasia in Hurler's syndrome: orthopaedic management after bone marrow transplantation. J Pediatr Orthop 16 (1996) 731-733
60. Krivit W., Peters C., and Shapiro E.G. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 12 (1999) 167-176
61. Krivit W. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Semin Immunopathol 26 (2004) 119-132
62. Rovelli A.M., and Steward C.G. Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directions. Bone Marrow Transplant 35 Suppl 1 (2005) S23-S26
63. Peters C., and Steward C.G. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 31 (2003) 229-239
64. Kurtzberg J., Kosaras B., Stephens C., and Snyder E.Y. Umbilical cord blood cells engraft and differentiate in neural tissues after human transplantation. Biol Blood Marrow Transplant 9 (2003) 128-129
65. Escolar M.L., Poe M.D., Provenzale J.M., Richards K.C., Allison J., Wood S., et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 352 (2005) 2069-2081
66. Wynn R.F., Wraith J.E., Mercer J., O'Meara A., Tylee K., Thornley M., et al. Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. J Pediatr 154 (2009) 609-611
67. Bergstrom S.K., Quinn J.J., Greenstein R., and Ascensao J. Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review. Bone Marrow Transplant 14 (1994) 653-658
68. Coppa G.V., Gabrielli O., Zampini L., Jetzequel A.M., Miniero R., Busca A., et al. Bone marrow transplantation in Hunter syndrome. J Inherit Metab Dis 18 (1995) 91-92
69. Guffon N., Bertrand Y., Forest I., Fouilhoux A., and Froissart R. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J Pediatr 154 (2009) 733-737
70. Peters C., and Krivit W. Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome). Bone Marrow Transplant 25 (2000) 1097-1099
71. Vellodi A., Young E., Cooper A., Lidchi V., Winchester B., and Wraith J.E. Long-term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis 22 (1999) 638-648
72. Mullen C.A., Thompson J.N., Richard L.A., and Chan K.W. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia. Bone Marrow Transplant 25 (2000) 1093
73. Gungor N., and Tuncbilek E. Sanfilippo disease type B. A case report and review of the literature on recent advances in bone marrow transplantation. Turkish J Pediatr 37 (1995) 157-163
74. Vellodi A., Young E., New M., Pot-Mees C., and Hugh-Jones K. Bone marrow transplantation for Sanfilippo disease type B. J Inherit Metab Dis 15 (1992) 911-918
75. Herskhovitz E., Young E., Rainer J., Hall C.M., Lidchi V., Chong K., et al. Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up. J Inherit Metab Dis 22 (1999) 50-62
76. Lee V., Li C.K., Shing M.M., et al. Umbilical cord blood transplantation for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Bone Marrow Transplant 26 (2000) 455-458
77. Messina C., Rampazzo A., Cesaro S., Monciotti C., Gasparotto N., Tomanin R., et al. Eighteen-year follow-up of the first Italian MPSI patient treated with bone marrow transplantation. Bone Marrow Transplant 41 (2008) 905-906
78. McKinnis E.J., Sulzbacher S., Rutledge J.C., Sanders J., and Scott C.R. Bone marrow transplantation in Hunter syndrome. J Pediatr 129 (1996) 145-148
79. Warkentin P.I., Dixon Jr. M.S., Schafer I., Strandjord S.E., and Coccia P.F. Bone marrow transplantation in Hunter syndrome: a preliminary report. Birth Defects 22 (1986) 31-39
80. Lakshminarayanan S., Szabolcs P., Prasad V.K., Parikh S., Allison J., Wood S.J., et al. Transplant outcomes and stabilization of neurological function in young children with MPS III (Sanfilippo syndrome) after unrelated donor umbilical cord blood transplantation [abstract]. ASH Annual Meeting Abstracts 106 (2005) 2050
81. Desai S., Hobbs J.R., Hugh-Jones K., Williamson S., Barnes S., Kendra J., et al. Morquio's disease (mucopolysaccharidosis type IV) treated by bone marrow transplant. Exp Hematol 11 (1983) 98-100
82. Yabe H., and Kato S. [Result of allogeneic bone marrow transplantation from unrelated donor]. Rinsho Ketsueki Jpn J Clin Hematol 31 (1990) 614-619
83. McGovern M.M., Ludman M.D., Short M.P., Steinfeld L., Kattan M., Raab E.L., et al. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT. Birth Defects 22 (1986) 41-53
84. Yamada Y., Kato K., Sukegawa K., Tomatsu S., Fukuda S., Emura S., et al. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant 21 (1998) 629-634